title: Thymidine phosphorylase (TP) activation: convenience through innovation.
authors.affiliation: University Hospital Gasthuisberg, Leuven, Belgium. eric.vancutsem@uz.kuleuven.ac.be
authors.forename: E
authors.initials: E
authors.lastname: Van Cutsem
authors.forename: D
authors.initials: D
authors.lastname: Cunningham
authors.forename: P M
authors.initials: PM
authors.lastname: Hoff
authors.forename: J
authors.initials: J
authors.lastname: Maroun
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology* / Q000627:therapeutic use; D000069287:Capecitabine; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D004789:Enzyme Activation / Q000187:drug effects; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D013939:Thymidine Phosphorylase / Q000378:metabolism*
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D013939:Thymidine Phosphorylase; D005472:Fluorouracil